Clinical Trials on Carcinosarcoma, Ovarian
Total 4825 results
-
National Cheng-Kung University HospitalCompletedFallopian Tube Cancer | Peritoneal Carcinoma | Ovarian Neoplasms Malignant (Excl Germ Cell)
-
Sorlandet Hospital HFUniversity of SurreyCompleted
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated CarcinomaUnited States
-
AGO Study GroupMerck Sharp & Dohme LLCCompletedCarcinosarcoma | Leiomyosarcoma | Mesenchymal TumorGermany
-
Mỹ Đức HospitalRecruitingProgestins Primed Ovarian StimulationVietnam
-
Instituto BernabeuRecruitingIVF | LOW OVARIAN RESPONSESpain
-
Royan InstituteCompletedPoor Ovarian Response | AccupunctureIran, Islamic Republic of
-
Uludag UniversityCompleted
-
Alaa Fouli Gaber EbrahimUnknownOvarian Stimulation in ICSIEgypt
-
Guangzhou First People's HospitalUnknownLow Ovarian Reserve | GH
-
Shanghai Gynecologic Oncology GroupZhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; Shanghai Zhongshan...Active, not recruitingFallopian Tube Carcinoma | Ovarian Epithelial Cancer Recurrent | Primary Peritoneal CarcinomaChina
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Ovarian Carcinoma | Ovarian Clear Cell AdenocarcinomaUnited States, Korea, Republic of
-
Gdynia Oncology CenterSuspendedMalnutrition | Ovarian Epithelial Cancer | AscitesPoland
-
TetraLogic PharmaceuticalsCompletedRelapsed Epithelial Ovarian Cancer | Relapsed Primary Peritoneal Cancer | Relapsed Fallopian Tube CancerUnited States
-
Catholic University of the Sacred HeartCompletedOvarian Epithelial Cancer Recurrent
-
University of NottinghamCompletedInfertility | Ovarian Aging | Diminished Ovarian Reserve (DOR) | Predicted Poor-respondersUnited Kingdom
-
Cybrexa TherapeuticsNot yet recruitingPlatinum-resistant Ovarian Cancer | Refractory Ovarian Carcinoma
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT)Active, not recruitingOvarian Neoplasms | Ovarian, Fallopian Tube and Primary Peritoneal CarcinomaUnited States, Netherlands, Spain, Finland, Italy, Poland, Belgium, Canada, France, Germany, Romania, Ukraine, Norway, United Kingdom, Israel, Greece, Denmark, Belarus, Czechia
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Stage III Fallopian Tube Cancer | Stage II Ovary Cancer | Stage II Ovarian Cancer | Stage III Ovary Cancer and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedFamilial Premature Ovarian FailureFrance
-
Assistance Publique - Hôpitaux de ParisCompletedInfertility | Primary Ovarian InsufficiencyFrance
-
Benha UniversityCompletedOvarian HyperstimulationEgypt
-
EugoniaCompletedInfertility | Premature Ovarian FailureGreece
-
EugoniaCompletedInfertility | Premature Ovarian FailureGreece
-
Centre Francois BaclesseGroupement Interrégional de Recherche Clinique et d'InnovationCompletedOvarian Cancer With Peritoneal CarcinosisFrance
-
Instituto de Investigacion Sanitaria La FeUnknownPremature Ovarian Failure (POF)Spain
-
Taipei Veterans General Hospital, TaiwanNational YangMing UniversityCompletedDehydroepiandrosterone | DHEAS | Gene Expression of Cumulus Cells. | Ovarian Hyper-stimulation Protocol. | Artificial Reproduction Technology.Taiwan
-
BioromaUnknownOvarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome | Invitro FertilizationItaly
-
University Hospital, ToursUnknown
-
University of ChicagoSuspendedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Brenner Tumor | Malignant Ascites | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer and other conditionsUnited States
-
Fudan UniversityNot yet recruitingRecurrent Ovarian CancerChina
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent Platinum-resistant Ovarian CancerChina
-
West China Second University HospitalRecruitingNeoadjuvant Chemotherapy | Epithelial Carcinoma, OvarianChina
-
Cukurova UniversityRecruitingEpithelial Ovarian Cancer | Rectosigmoid Cancer MetastaticTurkey
-
Haukeland University HospitalHelse Stavanger HF; Sorlandet Hospital HFRecruiting
-
Marker Therapeutics, Inc.TerminatedOvarian Cancer | Platinum Sensitive Ovarian CancerUnited States
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
Jonsson Comprehensive Cancer CenterCompleted
-
National Cancer Center, KoreaAjou UniversityCompletedEpithelial Ovarian CancerKorea, Republic of
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Ovarian CancerChina
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
PEDRO VILLAREJO CAMPOSUniversity of Castilla-La Mancha; Hospital General de Ciudad RealUnknownEpithelial Ovarian CancerSpain
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Mateon TherapeuticsTerminatedPlatinum Resistant Ovarian CancerUnited States, Belgium, Germany
-
Charite University, Berlin, GermanyWithdrawnRight Ventricular Function and Venous ReturnGermany